[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Bioimpedance Analyzers Market Size, Trends, Analysis, and Outlook By Product (Multi-frequency, Single-frequency, Dual-frequency), By Modality (Wired, Wireless), By Usage (Consumer Grade, Professional Grade), By Application (Whole-body Measurement, Segmental Body Measurement), By End-User (Hospitals, Clinics, Fitness Clubs & Wellness Centers, Others), by Country, Segment, and Companies, 2024-2032

April 2024 | 205 pages | ID: B1E3768E2E78EN
VPAResearch

US$ 3,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Bioimpedance Analyzers market size is poised to register 10.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Bioimpedance Analyzers market across By Product (Multi-frequency, Single-frequency, Dual-frequency), By Modality (Wired, Wireless), By Usage (Consumer Grade, Professional Grade), By Application (Whole-body Measurement, Segmental Body Measurement), By End-User (Hospitals, Clinics, Fitness Clubs & Wellness Centers, Others)

The bioimpedance analyzers market is driven by the growing interest in body composition analysis, advancements in electrical impedance technology, and the need for non-invasive physiological assessments. By 2030, the market is expected to witness significant growth, fueled by innovations in multi-frequency bioimpedance devices, segmental analysis algorithms, and wearable sensors. Further, expanding applications in nutrition assessment, fitness monitoring, and disease management are anticipated to drive market expansion, enabling healthcare providers, researchers, and fitness professionals to assess hydration status, muscle mass, and metabolic health with precision and convenience.

Bioimpedance Analyzers Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Bioimpedance Analyzers market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Bioimpedance Analyzers survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Bioimpedance Analyzers industry.

Key market trends defining the global Bioimpedance Analyzers demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Bioimpedance Analyzers Market Segmentation- Industry Share, Market Size, and Outlook to 2032

The Bioimpedance Analyzers industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Bioimpedance Analyzers companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Bioimpedance Analyzers industry

Leading Bioimpedance Analyzers companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Bioimpedance Analyzers companies.

Bioimpedance Analyzers Market Study- Strategic Analysis Review

The Bioimpedance Analyzers market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
  • Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
  • Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
  • Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
  • Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Bioimpedance Analyzers Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Bioimpedance Analyzers industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.

Bioimpedance Analyzers Country Analysis and Revenue Outlook to 2032

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.

North America Bioimpedance Analyzers Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Bioimpedance Analyzers market segments. Similarly, Strong market demand is encouraging Canadian Bioimpedance Analyzers companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Bioimpedance Analyzers market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Bioimpedance Analyzers Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Bioimpedance Analyzers industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Bioimpedance Analyzers market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Bioimpedance Analyzers Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Bioimpedance Analyzers in Asia Pacific. In particular, China, India, and South East Asian Bioimpedance Analyzers markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.

Latin America Bioimpedance Analyzers Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Bioimpedance Analyzers Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Bioimpedance Analyzers market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Bioimpedance Analyzers.

Bioimpedance Analyzers Market Company Profiles

The global Bioimpedance Analyzers market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Bodystat Ltd, Charder Electronic Co. Ltd, EVOLT 360 Pty Ltd, Fook Tin Technologies Ltd, InBody Co. Ltd, Maltron International Ltd, Omron Corp, RJL Systems Inc, seca GmbH & Co. KG, Selvas Healthcare Inc, Tanita Corp.

Recent Bioimpedance Analyzers Market Developments

The global Bioimpedance Analyzers market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Bioimpedance Analyzers Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • SWOT Profile
  • Market Dynamics- Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • Macroeconomic Impact Analysis
  • Case Scenarios- Low, Base, High
Market Segmentation:

By Product

Multi-frequency

Single-frequency

Dual-frequency

By Modality

Wired

Wireless

By Usage

Consumer Grade

Professional Grade

By Application

Whole-body Measurement

Segmental Body Measurement

By End-User

Hospitals

Clinics

Fitness Clubs & Wellness Centers

Others

Geographical Segmentation:
  • North America (3 markets)
  • Europe (6 markets)
  • Asia Pacific (6 markets)
  • Latin America (3 markets)
  • Middle East Africa (5 markets)
Companies

Bodystat Ltd

Charder Electronic Co. Ltd

EVOLT 360 Pty Ltd

Fook Tin Technologies Ltd

InBody Co. Ltd

Maltron International Ltd

Omron Corp

RJL Systems Inc

seca GmbH & Co. KG

Selvas Healthcare Inc

Tanita Corp

Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY

1.1 Bioimpedance Analyzers Market Overview and Key Findings, 2024
1.2 Bioimpedance Analyzers Market Size and Growth Outlook, 2021- 2030
1.3 Bioimpedance Analyzers Market Growth Opportunities to 2030
1.4 Key Bioimpedance Analyzers Market Trends and Challenges
  1.4.1 Bioimpedance Analyzers Market Drivers and Trends
  1.4.2 Bioimpedance Analyzers Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Bioimpedance Analyzers Companies

2. BIOIMPEDANCE ANALYZERS MARKET SIZE OUTLOOK TO 2030

2.1 Bioimpedance Analyzers Market Size Outlook, USD Million, 2021- 2030
2.2 Bioimpedance Analyzers Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024

3. BIOIMPEDANCE ANALYZERS MARKET- STRATEGIC ANALYSIS REVIEW

3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis

4. BIOIMPEDANCE ANALYZERS MARKET SEGMENTATION ANALYSIS AND OUTLOOK

4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Multi-frequency
Single-frequency
Dual-frequency
By Modality
Wired
Wireless
By Usage
Consumer Grade
Professional Grade
By Application
Whole-body Measurement
Segmental Body Measurement
By End-User
Hospitals
Clinics
Fitness Clubs & Wellness Centers
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030

5. REGION-WISE MARKET OUTLOOK TO 2030

5.1 Key Findings for Asia Pacific Bioimpedance Analyzers Market, 2025
5.2 Asia Pacific Bioimpedance Analyzers Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Bioimpedance Analyzers Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Bioimpedance Analyzers Market, 2025
5.5 Europe Bioimpedance Analyzers Market Size Outlook by Type, 2021- 2030
5.6 Europe Bioimpedance Analyzers Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Bioimpedance Analyzers Market, 2025
5.8 North America Bioimpedance Analyzers Market Size Outlook by Type, 2021- 2030
5.9 North America Bioimpedance Analyzers Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Bioimpedance Analyzers Market, 2025
5.11 South America Pacific Bioimpedance Analyzers Market Size Outlook by Type, 2021- 2030
5.12 South America Bioimpedance Analyzers Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Bioimpedance Analyzers Market, 2025
5.14 Middle East Africa Bioimpedance Analyzers Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Bioimpedance Analyzers Market Size Outlook by Application, 2021- 2030

6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030

6.1 US Bioimpedance Analyzers Market Size Outlook and Revenue Growth Forecasts
6.2 US Bioimpedance Analyzers Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Bioimpedance Analyzers Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Bioimpedance Analyzers Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Bioimpedance Analyzers Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Bioimpedance Analyzers Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Bioimpedance Analyzers Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Bioimpedance Analyzers Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Bioimpedance Analyzers Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Bioimpedance Analyzers Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Bioimpedance Analyzers Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Bioimpedance Analyzers Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Bioimpedance Analyzers Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Bioimpedance Analyzers Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Bioimpedance Analyzers Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Bioimpedance Analyzers Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Bioimpedance Analyzers Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Bioimpedance Analyzers Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Bioimpedance Analyzers Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Bioimpedance Analyzers Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Bioimpedance Analyzers Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Bioimpedance Analyzers Industry Drivers and Opportunities

7. BIOIMPEDANCE ANALYZERS MARKET OUTLOOK ACROSS SCENARIOS

7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case

8. BIOIMPEDANCE ANALYZERS COMPANY PROFILES

8.1 Profiles of Leading Bioimpedance Analyzers Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Bodystat Ltd
Charder Electronic Co. Ltd
EVOLT 360 Pty Ltd
Fook Tin Technologies Ltd
InBody Co. Ltd
Maltron International Ltd
Omron Corp
RJL Systems Inc
seca GmbH & Co. KG
Selvas Healthcare Inc
Tanita Corp.

9. APPENDIX

9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information


More Publications